74 results
8-K/A
EX-10.1
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
; Financial Statements; Financial Condition; No Material Adverse Change; Books and Records
Solvency
Payment of Taxes
Environmental Matters
Material … or Acquisition of Subsidiaries
Post-Closing Requirements
Environmental
Inventory; Returns; Maintenance of Properties
Regulatory Obligations; Maintenance
8-K
EX-2.1
eywtirl0luc4 iapk4
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
424B3
yz889g3zl9jrg5
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
vbe8yi mub
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
089rr2x sppzo0o
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
cy0jyxb
16 Jun 23
Business combination disclosure
8:08am
425
oqwjd5
16 Jun 23
Business combination disclosure
7:09am
8-K
EX-2.1
ddotu
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
EX-1.1
i834nhb v7sqnjja6d0
18 May 23
Other Events
5:02pm